Financials

%ChgLast 12MReverse

	FY202312/31/2023	FY202412/31/2024	FY202512/31/2025	Last 12M03/31/2026
Cash and Cash Equivalents	1,123.7	1,298.3	781.1	750.7
Short Term Investments	-	-	-	-
Cash and Short Term Investments	1,123.7	1,298.3	781.1	750.7
Net Receivables	230.1	224.0	201.7	222.5
Inventory	29.5	38.1	38.2	31.6
Other Current Assets	40.1	36.0	2.1	39.3
Total Current Assets	1,489.0	1,663.9	1,087.3	1,132.3
Property, Plant & Equipment	72.1	56.6	53.1	50.5
Long Term Investments	-	-	-	-
Other Non-Current Assets	80.3	81.5	137.6	106.0
Total Non-Current Assets	2,903.3	1,852.6	2,013.5	1,674.9
Total Assets	4,392.4	3,516.5	3,100.8	2,807.3
Account Payables	43.6	33.1	48.0	45.2
Short Term Debt	-	550.7	11.0	-
Deferred Revenue	95.7	79.3	62.3	65.7
Other Current Liabilities	167.3	69.3	187.2	102.1
Total Current Liabilities	420.6	941.5	404.7	404.9
Long Term Debt	1,538.7	991.4	994.9	995.8
Other Non-Current Liabilities	1.1	0.7	0.6	0.6
Total Non-Current Liabilities	1,645.7	1,083.9	1,310.4	1,066.1
Total Liabilities	2,066.3	2,025.4	1,715.1	1,470.9
Common Stock	0.2	0.2	0.2	0.2
Retained Earnings	-15,228.7	-16,229.9	-16,430.2	-16,494.1
Total Stockholders Equity	2,326.1	1,491.1	1,385.7	1,336.3
Total Liabilities and Equity	4,392.4	3,516.5	3,100.8	2,807.3

Teladoc Health, Inc.(TDOC US)